AR218620A1 - Metodo para preparar nuevos derivados ferricos de doxorrubicina - Google Patents

Metodo para preparar nuevos derivados ferricos de doxorrubicina

Info

Publication number
AR218620A1
AR218620A1 AR266173A AR26617377A AR218620A1 AR 218620 A1 AR218620 A1 AR 218620A1 AR 266173 A AR266173 A AR 266173A AR 26617377 A AR26617377 A AR 26617377A AR 218620 A1 AR218620 A1 AR 218620A1
Authority
AR
Argentina
Prior art keywords
doxorrubicine
derivatives
preparing new
new ferric
ferric
Prior art date
Application number
AR266173A
Other languages
English (en)
Spanish (es)
Original Assignee
Gosalvez M
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Gosalvez M filed Critical Gosalvez M
Application granted granted Critical
Publication of AR218620A1 publication Critical patent/AR218620A1/es

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H15/00—Compounds containing hydrocarbon or substituted hydrocarbon radicals directly attached to hetero atoms of saccharide radicals
    • C07H15/20—Carbocyclic rings
    • C07H15/24—Condensed ring systems having three or more rings
    • C07H15/252—Naphthacene radicals, e.g. daunomycins, adriamycins
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Biotechnology (AREA)
  • Engineering & Computer Science (AREA)
  • Molecular Biology (AREA)
  • Genetics & Genomics (AREA)
  • Biochemistry (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Saccharide Compounds (AREA)
AR266173A 1976-01-16 1977-01-12 Metodo para preparar nuevos derivados ferricos de doxorrubicina AR218620A1 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
ES444380A ES444380A1 (es) 1976-01-16 1976-01-16 Un procedimiento para preparar derivados metalicos antraci- clinicos.

Publications (1)

Publication Number Publication Date
AR218620A1 true AR218620A1 (es) 1980-06-30

Family

ID=8470743

Family Applications (1)

Application Number Title Priority Date Filing Date
AR266173A AR218620A1 (es) 1976-01-16 1977-01-12 Metodo para preparar nuevos derivados ferricos de doxorrubicina

Country Status (29)

Country Link
US (1) US4138480A (ko)
JP (1) JPS52111555A (ko)
AR (1) AR218620A1 (ko)
AT (1) AT349634B (ko)
AU (1) AU513698B2 (ko)
BE (1) BE850438A (ko)
CA (1) CA1070680A (ko)
CH (1) CH629219A5 (ko)
DD (1) DD129452A5 (ko)
DE (1) DE2701405C2 (ko)
DK (1) DK11877A (ko)
EG (1) EG12735A (ko)
ES (1) ES444380A1 (ko)
FI (1) FI770115A (ko)
FR (1) FR2338285A1 (ko)
GB (1) GB1568263A (ko)
GR (1) GR70696B (ko)
HU (1) HU177832B (ko)
IE (1) IE44689B1 (ko)
IL (1) IL51264A (ko)
NL (1) NL7700379A (ko)
NO (1) NO770122L (ko)
NZ (1) NZ183084A (ko)
PH (1) PH16582A (ko)
PL (1) PL108660B1 (ko)
PT (1) PT66067B (ko)
SE (1) SE7700398L (ko)
SU (1) SU886748A3 (ko)
YU (1) YU5477A (ko)

Families Citing this family (20)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US2959798A (en) * 1958-03-24 1960-11-15 Champlin Oil & Refining Co Pipe line cleaner
US4337335A (en) * 1978-05-18 1982-06-29 Schering Corporation Transition metal salt complexes of polyamino organic compounds
IT1184161B (it) * 1985-03-14 1987-10-22 Franco Conti Derivati del chitosano costituiti da complessi di coordinazione con ioni ferrosi
JPS63310830A (ja) * 1987-06-10 1988-12-19 Meiji Seika Kaisha Ltd 抗レトロウイルス剤
GB9613182D0 (en) * 1996-06-24 1996-08-28 Nycomed Imaging As Method
NL1009226C2 (nl) * 1998-05-20 1999-11-24 Faculteit Geneeskunde Universi Toepassing van een nucleïnezuur-bindend chemotherapeutisch agens, een farmaceutisch preparaat en een geneesmiddelcombinatie.
WO2004087097A2 (en) * 2003-03-31 2004-10-14 Yissum Research Development Company Of The Hebrew University Of Jerusalem Stable liposomes or micelles comprising a sphinolipid and a peg-lipopolymer
CN101102752A (zh) * 2004-11-15 2008-01-09 耶路撒冷希伯来大学伊萨姆研发公司 联合优选为神经酰胺与细胞毒性药物的联合疗法
WO2008100591A2 (en) * 2007-02-14 2008-08-21 The General Hospital Corporation Modulation of nitric oxide signaling to normalize tumor vasculature
ES2609931T3 (es) 2010-06-18 2017-04-25 Myriad Genetics, Inc. Métodos y materiales para evaluar la pérdida de heterocigosidad
DK3109325T3 (en) 2010-08-24 2019-01-28 Dana Farber Cancer Inst Inc Methods for predicting anticancer response
WO2012174378A2 (en) 2011-06-17 2012-12-20 Myriad Genetics, Inc. Methods and materials for assessing allelic imbalance
DK2794907T4 (da) 2011-12-21 2023-02-27 Myriad Genetics Inc Fremgangsmåder og materialer til vurdering af tab af heterozygositet
NZ628813A (en) 2012-02-23 2015-10-30 Univ Denmark Tech Dtu Methods for predicting anti-cancer response
AU2013273466B2 (en) 2012-06-07 2018-11-01 Inserm (Institut National De La Sante Et De La Recherche Medicale) Methods for detecting inactivation of the homologous recombination pathway (BRCA1/2) in human tumors
US10308986B2 (en) 2013-03-14 2019-06-04 Children's Medical Center Corporation Cancer diagnosis, treatment selection and treatment
WO2014165785A2 (en) 2013-04-05 2014-10-09 Myriad Genetics, Inc. Methods and materials for assessing homologous recombination deficiency
CA2931181C (en) 2013-12-09 2023-01-24 Institut Curie Methods for detecting inactivation of the homologous recombination pathway (brca1/2) in human tumors
JP6877334B2 (ja) 2014-08-15 2021-05-26 ミリアド・ジェネティックス・インコーポレイテッド 相同組換え欠損を評価するための方法および材料
EP4141127B1 (en) 2021-08-30 2024-10-09 Zentrum Familiärer Brust- und Eierstockkrebs Universitätsklinik Köln Method for assessing homologous recombination deficiency in ovarian cancer cells

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3074927A (en) * 1960-04-12 1963-01-22 Paul D Saltman Metallic complexes of reducing sugars
YU33730B (en) * 1967-04-18 1978-02-28 Farmaceutici Italia Process for preparing a novel antibiotic substance and salts thereof
GB1469430A (en) * 1974-12-24 1977-04-06 Farmaceutici Italia Daunomycin derivatives

Also Published As

Publication number Publication date
CA1070680A (en) 1980-01-29
AU2131977A (en) 1978-07-20
PT66067A (en) 1977-02-01
IE44689B1 (en) 1982-02-24
YU5477A (en) 1982-06-30
CH629219A5 (de) 1982-04-15
HU177832B (en) 1981-12-28
IL51264A (en) 1980-05-30
DD129452A5 (de) 1978-01-18
JPS52111555A (en) 1977-09-19
FR2338285B1 (ko) 1980-03-14
PH16582A (en) 1983-11-22
SU886748A3 (ru) 1981-11-30
IL51264A0 (en) 1977-03-31
EG12735A (en) 1981-03-31
DK11877A (da) 1977-07-17
PL195344A1 (pl) 1978-08-14
PT66067B (en) 1978-06-23
BE850438A (fr) 1977-05-16
JPS6133039B2 (ko) 1986-07-31
NZ183084A (en) 1980-04-28
FR2338285A1 (fr) 1977-08-12
US4138480A (en) 1979-02-06
PL108660B1 (en) 1980-04-30
GR70696B (ko) 1982-12-30
DE2701405A1 (de) 1977-07-21
IE44689L (en) 1977-07-16
ES444380A1 (es) 1977-06-16
NO770122L (no) 1977-07-19
GB1568263A (en) 1980-05-29
DE2701405C2 (de) 1986-02-27
NL7700379A (nl) 1977-07-19
FI770115A (ko) 1977-07-17
AT349634B (de) 1979-04-10
SE7700398L (sv) 1977-07-17
ATA19677A (de) 1978-09-15
AU513698B2 (en) 1980-12-18

Similar Documents

Publication Publication Date Title
PL201586A1 (pl) Sposob wytwarzania nowych zwiazkow spiro-hydantionowych
MX4811E (es) Procedimiento para preparar derivados de prostaglandina
PL196505A1 (pl) Sposob wytwarzania nowych zwiazkow aminoalkiloheterocyklicznych
AR216898A1 (es) Procedimiento para preparar nuevas 1-amidino-3-fenilureas
AR218620A1 (es) Metodo para preparar nuevos derivados ferricos de doxorrubicina
AR230270A1 (es) Procedimiento para preparar nuevos derivados de 2-alquiltio-3(-alcanoil alcoxicarbonil)-5-halogeno-6-fenoxi-bencimidazol substituidos
MX4899E (es) Procedimiento para preparar derivados de espirohidantoina
NO147985C (no) Fremgangsmaate for fremstilling av meta-aryloksybenzaldehyder
AR221081A1 (es) Procedimiento para preparar derivados de fenoximetil-piperidino-propoxi-indol
PL215008A1 (pl) Sposob wytwarzania pochodnych piranonu-3
PL197372A1 (pl) Sposob wytwarzania pochodnych kanamycyny
AR216074A1 (es) Un procedimiento para preparar derivados de 7-fenil o 7-fenoxiacetilcefalosporina
PL200583A1 (pl) Sposob wytwarzania nowych pochodnych benzopiranu
MX4808E (es) Un proceso mejorado para preparar derivados de carbostirilo
PL200605A1 (pl) Sposob wytwarzania nowych pochodnych metioninoenkefaliny
MX4911E (es) Procedimiento para preparar derivados de quinoleina
MX4942E (es) Procedimiento para preparar derivados de benzodioxol
PL198878A1 (pl) Sposob wytwarzania pochodnych 2-chlorosulfinyloazetydynonu
RO73050A (ro) Procedeu pentru prepararea derivatilor aminochinazolinei substituite
AR214651A1 (es) Procedimiento para preparar nuevos derivados de coenzima b12
PL202660A1 (pl) Sposob wytwarzania nowych pochodnych spirooksazolidynodionu
PL201161A1 (pl) Sposob wytwarzania nowych pochodnych 9-chloroprednisolonu
PL203359A1 (pl) Sposob wytwarzania nowych zasadowo podstawionych o-propylooksymow
AR218865A1 (es) Metodo para preparar nuevos derivados de cinamamida
SE443778B (sv) Forfarande for framstellning av aryletrar av hydroxiaminer